Dopamine Justice Alliance
  • Home
  • About
    • About DJA
    • Dopamine Agonists
    • Tribute to Dad
    • About the Founder
    • The Masterplan
  • Legal Action and Support
    • Victim & Family Support
    • Peer Support
    • Past Legal Successes
  • Research
    • Neuro Interconnections
    • Family Dynamics &Traits
    • SEN & Early Intervention
    • Culture & Environment
    • Dementia Diagnosis
  • News and Blog
  • Contact
  • Donate
  • More
    • Home
    • About
      • About DJA
      • Dopamine Agonists
      • Tribute to Dad
      • About the Founder
      • The Masterplan
    • Legal Action and Support
      • Victim & Family Support
      • Peer Support
      • Past Legal Successes
    • Research
      • Neuro Interconnections
      • Family Dynamics &Traits
      • SEN & Early Intervention
      • Culture & Environment
      • Dementia Diagnosis
    • News and Blog
    • Contact
    • Donate
Dopamine Justice Alliance
  • Home
  • About
    • About DJA
    • Dopamine Agonists
    • Tribute to Dad
    • About the Founder
    • The Masterplan
  • Legal Action and Support
    • Victim & Family Support
    • Peer Support
    • Past Legal Successes
  • Research
    • Neuro Interconnections
    • Family Dynamics &Traits
    • SEN & Early Intervention
    • Culture & Environment
    • Dementia Diagnosis
  • News and Blog
  • Contact
  • Donate

The Yellow Card Scheme

  The Yellow Card Scheme, run by the UK's MHRA since 1964, is a voluntary system for reporting suspected adverse drug reactions (ADRs) from medicines, vaccines, devices, and more—anyone can submit, but there's no formal "enforcement" mechanism.rdtc+1

​

Reporting Process

Healthcare professionals and patients report suspicions (no proof needed) online at yellowcard.mhra.gov.uk, via app, or paper forms, prioritizing serious cases, black triangle (new) drugs, children, elderly, or off-label use. MHRA analyzes data for signals like label changes or withdrawals, but reporting is not mandatory except for certain professionals under legal duties.yellowcard.mhra+2

​

Outcomes and Limitations

Reports have led to safety updates (e.g., dopamine agonist warnings), but the scheme relies on vigilance—under-reporting is common, with no penalties for non-reporting unless negligence is proven in court. For your dopamine agonist advocacy, encourage victims to file Yellow Cards to build evidence for accountability.gov+1

​

  1. https://rdtc.nhs.uk/yellow-card/yellow-card-scheme/
  2. https://www.gov.uk/drug-safety-update/suspect-an-adverse-reaction-yellow-card-it
  3. https://assets.publishing.service.gov.uk/media/5a81ac1840f0b6230269890f/Healthcare-Professional-Yellow-Card-Reporting-Form_1_.pdf
  4. https://yellowcard.mhra.gov.uk/what-to-report
  5. https://awttc.nhs.wales/medicines-optimisation-and-safety/yellow-card-centre-wales/reporting-side-effects-of-medicines-and-vaccines/yellow-card-reporting-for-healthcare-professionals/
  6. https://www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals
  7. https://www.yccnorthwest.nhs.uk/reporting
  8. https://en.wikipedia.org/wiki/Yellow_Card_Scheme
  9. https://rdtc.nhs.uk/yellow-card/patient-self-reporting-of-adverse-drug-reactions/
  10. https://yellowcard.mhra.gov.uk.

  • Privacy Policy

Dopamine Justice Alliance

Copyright © 2026 Dopamine Justice Alliance - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept